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Diseases of the Breast
JR Harris, ME Lippman, M MorrowandS Hellman
Philadelphia, USA: Lippicott-Raven, 1996, pp 1056,
£118.00, ISBN 0 397 514 70 0.
This is atraditional, multiauthor, large textbook covering all aspects
of breast disease with over 100 contributors (mainly from the
United States), whose contributions have been pulled into a very
readable reference text with little overlap and a consistent style.
The text is logically broken up into sections on benign disease,
clinical evaluation and diagnosis, pathology, screening, treatment
and rehabilitation. I found the sections on pathology and aetiology
particularly helpful, as were those chapters dealing with benign
breast diseases, breast pain and pregnancy. I was also pleased to
see that, in addition to the usual general chapters on the manage-
ment of advanced breast cancer, chapters focusing on site-specific
problems were included rather than the typical simplistic approach
ofconsidering advanced breast cancer as a single entity. An inter-
esting section is included on rehabilitation, psychosocial issues
and quality of life which, while rather targeted to an American
readership, discussed many useful general issues.
Inevitably in a text of this size, production takes many months,
and as a result the latest references are from 1994. For many
sections this does not matter, but clearly in some areas, notably the
genetics of familial breast cancer, the role of adjuvant systemic
therapy in node-negative patients and new endocrine andcytotoxic
agents, there has been considerable progress over the past 2 years.
Reference texts are used for two purposes: firstly, to look up
information and, secondly, to obtain guidance on clinical manage-
ment. I feel that the second area was not given sufficient attention,
and there were very few recommendations orjudgements made on
the clinical use ofthe multiple treatment approaches now available
for both early and advanced breast cancer. Of note, despite the
large literature on the subject, there were no recommendations that
I could find on appropriate staging investigations. A schema or
flow diagram illustrating clinical management decisions would
have been a useful addition to each of the relevant chapters on
diagnosis, evaluation and treatment.
Notwithstanding all this, I found the book extremely useful. The
editors are to be congratulated on the layout and consistency ofthe
text, and I would certainly recommend Diseases ofthe Breast as a
reference text for every Breast Unit and Oncology Centre.
RE Coleman
Serotonin and the Scientific Basis of
Anti-emetic Therapy
Editedby DJM Reynolds, PLRAndrews and CJ Davis
Oxford Clinical Comminications: Oxford, UK, 1996, pp. 286,
£48.00, ISBN 1 85403 1058.
The book is based upon a meeting held in March 1995. It consists
of 25 chapters plus 23 abstracts presented at the above-mentioned
meeting. Each chapter is written by a different author, or authors,
all experienced in the field. As reflected in the title ofthebook,the
main focus is on the role ofserotonin and the 5-HT3 receptor in the
physiology of emesis. The tremendous progress made in the
understanding ofthe physiology and the possibilities for interven-
tion are well described, and all areas ofinterest are reviewed.
Both animal and human data are described. Clinical results
are only mentioned in three chapters describing the general
clinical approach to chemotherapy-induced emesis, the role of
5-HT3 receptor antagonists in radiotherapy-induced emesis and
a discussion on the differences between the three clinically avail-
able compounds.
The variety of authors is reflected in differences in style, but
most chapters are well written and the references are dated up to
1995. The two longest chapters (I and II) are written by Davis and
Andrews and give a historical background and introduction to the
subsequent chapters.
Chapter 25 and some ofthe abstracts form a bridge to the future
ofnon-5-HT3 antiemetics by describing promising preclinical data
with a selective NK1 receptor blocker.
This book is very informative for those interested in the scien-
tific background of emesis and its implications for intervention.
It represents one of the best available comprehensive sources on
this topic.
For clinicians dealing with emesis in daily practice, the given
information is very possibly one bridge too far.
Prof. Dr PHMde Mulder
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